特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
276812

遺伝子検査の世界市場:2020年~2024年

Genetic Testing Market by Product, End-user, Application, and Geography - Forecast and Analysis 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 171 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.64円
遺伝子検査の世界市場:2020年~2024年
出版日: 2019年11月14日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 171 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子検査市場は、遺伝子疾患および障害の有病率の上昇、先進的な遺伝子検査製品の承認の増加、遺伝子検査のコスト削減によって受検しやすくなったことなどが成長促進要因となり、予測期間中に12%以上のCAGRで拡大する見込みです。ただし、世界の遺伝子検査と研究に関する様々規制、製品リコールに関する問題、および熟練された遺伝専門家の不足などの要因が、予測期間中の遺伝子検査業界の成長を妨げる可能性があります。

当レポートでは、世界の遺伝子検査市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2019年)
  • 市場規模および予測(2019年~2024年)
  • 市場の見通し

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場セグメンテーション:製品別
  • 製品別比較:市場規模および予測(2019年~2024年)
  • 機器
  • 消耗品
  • 市場機会:製品別

第7章 市場セグメンテーション:エンドユーザー別

  • 臨床診断研究所
  • 病院
  • バイオ医薬品企業および研究センター

第8章 市場セグメンテーション:アプリケーション別

  • 予測および診断テスト
  • 出生前、新生児および着床前検査
  • 薬理ゲノム検査
  • 法医学、血縁関係、祖先検査

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2019年~2024年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第10章 顧客情勢

第11章 意思決定の枠組み

第12章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第13章 市場動向

  • 次世代シーケンシングの進歩
  • 早期の病気診断における直販の遺伝子検査採用の拡大
  • 薬物有害事象低減における薬理遺伝学的検査採用の拡大

第14章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競争シナリオ

第15章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

第16章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第17章 TECHNAVIOについて

図表

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendor offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Equipment - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Equipment - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Consumables - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Consumables - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Global genetic testing market segmentation by end-user 2019 (% share)
  • Exhibit 26: Global genetic testing market segmentation by application 2019 (% share)
  • Exhibit 27: Market share by geography 2019-2024 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 33: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 35: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Customer landscape
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Abbott Laboratories - Vendor overview
  • Exhibit 47: Abbott Laboratories - Product segments
  • Exhibit 48: Abbott Laboratories - Organizational developments
  • Exhibit 49: Abbott Laboratories - Geographic focus
  • Exhibit 50: Abbott Laboratories - Segment focus
  • Exhibit 51: Abbott Laboratories - Key offerings
  • Exhibit 52: Agilent Technologies Inc. - Vendor overview
  • Exhibit 53: Agilent Technologies Inc. - Business segments
  • Exhibit 54: Agilent Technologies Inc. - Organizational developments
  • Exhibit 55: Agilent Technologies Inc. - Geographic focus
  • Exhibit 56: Agilent Technologies Inc. - Segment focus
  • Exhibit 57: Agilent Technologies Inc. - Key offerings
  • Exhibit 58: bioMerieux SA - Vendor overview
  • Exhibit 59: bioMerieux SA - Business segments
  • Exhibit 60: bioMerieux SA - Organizational developments
  • Exhibit 61: bioMerieux SA - Geographic focus
  • Exhibit 62: bioMerieux SA - Key offerings
  • Exhibit 63: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 64: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 65: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 66: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 67: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 68: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 69: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 70: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 71: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 72: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 73: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 74: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 75: Illumina Inc. - Vendor overview
  • Exhibit 76: Illumina Inc. - Business segments
  • Exhibit 77: Illumina Inc. - Organizational developments
  • Exhibit 78: Illumina Inc. - Geographic focus
  • Exhibit 79: Illumina Inc. - Segment focus
  • Exhibit 80: Illumina Inc. - Key offerings
  • Exhibit 81: Myriad Genetics Inc. - Vendor overview
  • Exhibit 82: Myriad Genetics Inc. - Business segments
  • Exhibit 83: Myriad Genetics Inc. - Organizational developments
  • Exhibit 84: Myriad Genetics Inc. - Segment focus
  • Exhibit 85: Myriad Genetics Inc. - Key offerings
  • Exhibit 86: QIAGEN NV - Vendor overview
  • Exhibit 87: QIAGEN NV - Product segments
  • Exhibit 88: QIAGEN NV - Organizational developments
  • Exhibit 89: QIAGEN NV - Geographic focus
  • Exhibit 90: QIAGEN NV - Segment focus
  • Exhibit 91: QIAGEN NV - Key offerings
  • Exhibit 92: Quest Diagnostics Inc. - Vendor overview
  • Exhibit 93: Quest Diagnostics Inc. - Business segments
  • Exhibit 94: Quest Diagnostics Inc. - Organizational developments
  • Exhibit 95: Quest Diagnostics Inc. - Segment focus
  • Exhibit 96: Quest Diagnostics Inc. - Key offerings
  • Exhibit 97: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 98: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 99: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 100: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 101: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 102: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 103: Validation techniques employed for market sizing
  • Exhibit 104: Definition of market positioning of vendors
目次
Product Code: IRTNTR40152

About this market

Technavio's genetic testing market analysis considers sales from both equipment and consumable products. Our study also finds the sales of genetic testing in Asia, Europe, North America, and ROW. In 2019, the equipment segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing workload for performing high-throughput tests in clinical diagnostic facilities will play a significant role in the equipment segment to maintain its market position. Also, our global genetic testing market report looks at factors such as rising prevalence of genetic diseases and disorders, rising approval of advanced genetic testing products, and increasing affordability due to reduction in cost of genetic testing. However, varying regulations on genetic testing and research globally, issues related to product recalls, and lack of trained genetic professionals may hamper the growth of the genetic testing industry over the forecast period.

Overview

Rising approval of advanced genetic testing products

Commercial applications of genetic screening in human health management and the advent of whole genome sequencing have allowed vendors to offer a variety of innovative products in the global genetic testing market. The use of advanced technologies such as pharmacogenomics and companion diagnostics has helped vendors in assuring the safety of their products. Furthermore, the deployment of rapid and simplified technologies in genetic testing offers several benefits including the reduction in turnaround time, optimum resource use, and accuracy in genetic diagnosis. Thus, the rising approval of advanced genetic testing products will lead to the expansion of the global genetic testing market at a CAGR of over 12% during the forecast period.

Growing adoption of pharmacogenetic testing in reducing adverse drug events

The growing approval of new drug molecules and the rising demand for targeted therapies and personalized medicines have increased the adoption of pharmacogenomic testing by pharmaceutical companies. Pharmacogenomic testing combines the principles of pharmacology and genomics to study the response of an individual to any specific drug. The study of drug-specific responses allows pharmaceutical companies to prevent adverse drug incidence and ensure drug safety and performance during pre and post commercial stages. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global genetic testing market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global genetic testing market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genetic testing manufacturers, that include Abbott Laboratories, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.

Also, the genetic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Equipment - Market size and forecast 2019-2024
  • Consumables - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY END-USER

  • Clinical diagnostics laboratories
  • Hospitals
  • Biopharmaceutical companies and research centers
  • PART 08: MARKET SEGMENTATION BY APPLICATION
  • Predictive and diagnostic testing
  • Prenatal, newborn and preimplantation testing
  • Pharmacogenomic testing
  • Forensic, relationship and ancestry testing

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 10: CUSTOMER LANDSCAPE

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Advancements in next-generation sequencing
  • Growing adoption of direct-to-consumer genetic tests in early
  • disease diagnosis
  • Growing adoption of pharmacogenetic testing in reducing adverse
  • drug events

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

PART 16: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 17: EXPLORE TECHNAVIO

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.